As of 2026-04-05, the Relative Valuation of ADMA Biologics Inc (ADMA) is 14.76 USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.19 USD, the upside of ADMA Biologics Inc based on Relative Valuation is 60.6%.
The range of the Relative Valuation is 12.40 - 18.87 USD.
| Range | Selected | |
| Trailing P/E multiples | 23.5x - 30.6x | 26.2x |
| Forward P/E multiples | 19.9x - 23.0x | 21.4x |
| Fair Price | 12.40 - 18.87 | 14.76 |
| Upside | 35.0% - 105.3% | 60.6% |
| Date | P/E |
| 2026-04-02 | 14.90 |
| 2026-04-01 | 14.77 |
| 2026-03-31 | 14.60 |
| 2026-03-30 | 14.83 |
| 2026-03-27 | 14.99 |
| 2026-03-26 | 13.44 |
| 2026-03-25 | 15.61 |
| 2026-03-24 | 18.36 |
| 2026-03-23 | 22.03 |
| 2026-03-20 | 23.21 |
| 2026-03-19 | 24.35 |
| 2026-03-18 | 24.10 |
| 2026-03-17 | 26.18 |
| 2026-03-16 | 25.68 |
| 2026-03-13 | 24.56 |
| 2026-03-12 | 24.30 |
| 2026-03-11 | 25.40 |
| 2026-03-10 | 25.66 |
| 2026-03-09 | 25.63 |
| 2026-03-06 | 24.95 |
| 2026-03-05 | 25.45 |
| 2026-03-04 | 26.81 |
| 2026-03-03 | 26.55 |
| 2026-03-02 | 26.87 |
| 2026-02-27 | 25.24 |
| 2026-02-26 | 24.61 |
| 2026-02-25 | 25.42 |
| 2026-02-24 | 25.16 |
| 2026-02-23 | 26.40 |
| 2026-02-20 | 26.10 |
| 2026-02-19 | 26.45 |
| 2026-02-18 | 25.92 |
| 2026-02-17 | 25.85 |
| 2026-02-13 | 26.08 |
| 2026-02-12 | 25.27 |
| 2026-02-11 | 26.39 |
| 2026-02-10 | 26.39 |
| 2026-02-09 | 26.53 |
| 2026-02-06 | 26.63 |
| 2026-02-05 | 25.84 |
| 2026-02-04 | 26.73 |
| 2026-02-03 | 28.40 |
| 2026-02-02 | 28.37 |
| 2026-01-30 | 28.04 |
| 2026-01-29 | 27.57 |
| 2026-01-28 | 26.47 |
| 2026-01-27 | 26.87 |
| 2026-01-26 | 27.49 |
| 2026-01-23 | 27.12 |
| 2026-01-22 | 28.20 |